Imunon, Inc. Announces 2026 Annual Meeting Results and Amendment to Stock Incentive Plan

On June 16, 2026, Imunon, Inc. held its 2026 Annual Meeting of Stockholders. Key outcomes included the election of Mr. Frederick J. Fritz and Ms. Christine A. Pellizzari as Class I directors to serve until the 2029 annual meeting. Stockholders also ratified the appointment of WithumSmith + Brown, PC as the independent registered public accounting firm for the fiscal year ending December 31, 2026. Furthermore, stockholders approved an amendment to the IMUNON, Inc. 2018 Stock Incentive Plan. This amendment increases the aggregate number of shares of common stock available for delivery under the plan by 1,000,000 shares, bringing the new aggregate limit to 1,265,004 shares. Additionally, the 2025 compensation of the company's named executive officers was approved on an advisory basis (Say-on-Pay). The meeting saw a quorum with approximately 45.4% of outstanding shares represented. directors Dr. Stacy R. Lindborg, Mr. Michael H. Tardugno, Mr. James E. Dentzer, and Dr. Donald P. Braun continue their service on the board.